
|Articles|October 4, 2007
Ranbaxy gets agency nod for generic Biaxin suspension
Clarithromycin oral suspension approved for Ranbaxy Pharmaceuticals
Advertisement
Clarithromycin for Oral Suspension, USP, has been approved by the FDA for Ranbaxy Pharmaceuticals in strengths of 125 mg/5 ml and 250 mg/5 ml. The agent is bioequivalent to Biaxin Granules in the same strengths from Abbott Laboratories. Clarithromycin is indicated for the treatment of mild to moderate infections causes by susceptible microorganisms.
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
3
Pharmacists Want Prescribing Authority With Proper Training, Support
4
What’s Next for Pneumococcal Vaccination? An Expert Weighs In
5






























